Navigation Links
SuperGen Reports 2007 Fourth Quarter and Annual Financial Results
Date:3/3/2008

I-EORTC

International Conference, the Company announced the following: MP470, a

clinical-stage multi-targeted tyrosine kinase inhibitor, demonstrates

preclinical synergy with DNA damaging agents (Poster A173, Abstract

1026); S110, a decitabine-derived DNA demethylating agent, shows

improved pre-clinical activity due to increased drug delivery and

stability (Poster 140, Abstract 1038); and, the proprietary CLIMB(TM)

technology was successful in the lead development and design of small

molecule JAK2 and Pim kinase inhibitors (Posters C200, Abstract 907 and

C208, Abstract 985). Also, Dr. Peter A. Jones, Director of USC's Norris

Cancer Center, further discussed S110 in a plenary session on cancer

epigenetics.

-- The Company announced during an oral presentation at the American

Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in

Los Angeles that MP470, a clinical-stage multi-targeted tyrosine kinase

inhibitor, is cytotoxic to glioblastoma multiforme cell lines (Abstract

178). Activity was also demonstrated in vivo in a glioblastoma

multiforme xenograft model. Evidence presented suggests that MP470

inhibits DNA damage repair through suppression of a critical DNA repair

protein, Rad51. Dr. James Welsh of the University of Arizona, who

conducted these pre-clinical studies, also revealed that the pre-

clinical activity of MP470 against glioblastoma multiforme cells is

synergistic with radiation.

December 2007:

-- As part of a series of presentations at the American Society of

Hematology's 49th Annual Meeting, the Company described how its

proprietary CLIMB technology was used in lead development and design of

small molecule Pim kinase inhibitors (Poster 845, Abstract 2655) and

how its novel decitabine dinucleotide
'/>"/>

SOURCE SuperGen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. SuperGen to Announce 2007 Fourth Quarter and Fiscal Year-End Financial Results March 3, 2008
2. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
3. Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
4. Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results
5. Genetic Engineering & Biotechnology News reports on advances in miRNA
6. Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results
7. Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
8. Cepheid Reports Fourth Quarter and Full Year 2007 Results
9. Strategic Diagnostics Reports Fourth Quarter and Full-Year Financial Results
10. US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results
11. Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 Per Share for the Fourth Quarter; Adjusted Earnings Were $3.16 Per Share for 2007 and $0.79 Per Share for the Fourth Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... DC (PRWEB) January 14, 2014 Carahsoft ... for Thursday, January 23, 2014 at 2pm EST (11am ... Knowledge.” The topic focuses on how technology can turn ... critical decisions for government agencies. The online webinar will ...
(Date:1/14/2014)... pet owners drew up their lists of New Year,s resolutions for ... of my furry companion." Nowadays there are pet salons, dog and ... take the little canine or feline darlings along wherever mommy or ... pricey toys at the pet store. But anyone who has ever ...
(Date:1/14/2014)... DIEGO and BETHESDA, Md. ... are joining together with two institutes from the National ... reliable tools for bringing safer, more effective treatments to ... the National Center for Advancing Translational Sciences (NCATS) and ...
(Date:1/14/2014)... 14, 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), a ... innovative therapies addressing major unmet medical needs using ... Notice of Allowance from the United States Patent ... compounds (sd-rxRNA®), for the treatment of fibrosis. The ...
Breaking Biology Technology:Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3
... Crosse, Wis. -- Firstlogic Inc. , a ... Corp. approved technology from Firstlogics Information Quality ... ,Oracle Warehouse Builder is a business intelligence integration ... allows users to design their business intelligence application ...
... medial errors, improve patient safety and run a ... to automate the costly processes of data collection, ... 5 percent of healthcare organizations research outcome and ... revenue enhancements and quality of life improvements associated ...
... reducing surgery delays and controlling instrument and staff costs ... trays by using a new surgical instrument management system ... ,Gundersen Lutheran operates a teaching hospital with 325 licensed ... practices, community clinics, eye clinics and pharmacies. It has ...
Cached Biology Technology:Real-Time Data Warehouse Benefits Healthcare Providers 2Real-Time Data Warehouse Benefits Healthcare Providers 3Gunderson Lutheran Implements Instrument Management Systems 2
(Date:4/23/2014)... Wash. -- Like a hungry diner ripping open a ... into electricity must tear open a hydrogen molecule. Now ... holding onto the two halves of its hydrogen feast. ... how to make the catalyst work better for alternative ... scientists have shown precisely where the hydrogen halves end ...
(Date:4/23/2014)... A team of researchers in Korea who ... brains of nonhuman primates and assessed cell survival ... that the hNSCs had differentiated into neurons at ... The study will be published in a future ... currently freely available on-line as an unedited early ...
(Date:4/23/2014)... found evidence of an interaction between prenatal smoking ... in children, especially in girls. , "The interesting ... prenatal smoking will have behavioral problems. Some ... Assistant Professor at Sam Houston State University, College ... study. "One possible explanation for this is ...
Breaking Biology News(10 mins):Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Study finds long-term survival of human neural stem cells transplanted into primate brain 2Genetics risk, prenatal smoking may predict behavioral problems 2
... likely require an old ally Mother Nature and ... for cutting greenhouse gas emissions 20% by 2020, according ... says that despite rising population and affluence, the EU ... will likely require more than energy savings, new technologies ...
... Australia now have greater access to the Japanese market ... of Primary Industries (DPI). Trials undertaken at NSW ... at temperatures of 2 or 3C can effectively kill ... days. Cold treatment at these temperatures provides greater ...
... still some places available on two international workshops for ... Netherlands) is organizing at the start of 2008. The ... sanitary engineering,. The two workshops are to be held ... or attended seperately. The Delft University of Technology ...
Cached Biology News:European Union forests expanding, absorbing carbon at surprisingly high rate: study 2European Union forests expanding, absorbing carbon at surprisingly high rate: study 3Cold treatment opens doors for citrus exports to Japan 2
... WinList come straight from the folks who ... automatic region positioning, N-Stat regions, and presentation-quality ... thoughtful conversations, and careful design. Of course, ... are still there, too. WinList leads the ...
Insect Cell Lysis Buffer 50 ml...
Recognizes the VZV nucleocapsid by indirect immunofluorescence and immunoprecipitation. Shows cross-reactivity to HSV....
Rabbit polyclonal to Orexin Prepro ( Abpromise for all tested applications). entrezGeneID: 3060 SwissProtID: O43612...
Biology Products: